Abipre 5/40 mg
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Taeguk Pharmaceutical Co., Ltd.
MFDS item code 201906398 · Approved 2019.09.10
This product's status changed to Expired on 2024.09.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively manage blood pressure in patients with essential hypertension who have difficulties controlling blood pressure with either amlodipine or olmesartan medoxomil alone. By stabilizing blood pressure, it reduces the risk of cardiovascular diseases and improves overall health.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medication may be considered. The maximum dose of this medication is 10/40 mg. The maximum blood pressure-lowering effect occurs within 2 weeks of administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient’s blood pressure response into account. The recommended doses are as follows. - 5/20 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or olmesartan medoxomil 20 mg monotherapy. - 10/20 mg: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 mg monotherapy. - 5/40 mg: For patients whose blood pressure is not adequately controlled with 5/20 mg. - 10/40 mg: For patients whose blood pressure is not adequately controlled with 5/40 mg. ∘Patients with renal impairment: This medication has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil for patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 mg once daily. This medication is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients on dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil for patients with moderate hepatic impairment is 10 mg once daily, and the maximum dose is 20 mg once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment who are already receiving other antihypertensive medications and/or diuretics. This medication should not be administered to patients with severe hepatic impairment. (See section 2. Patients who should not be administered this medication under Precautions for Use.) ∘Elderly patients: In general, start treatment at a low dose. When adjusting the dose, consider the patient’s renal or cardiac function and comorbid conditions. In elderly patients, blood pressure should be monitored closely and more frequently.
∘Pediatric patients: The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age.
This drug can cause severe injury or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. It is contraindicated for those allergic to any components of this medication or similar drugs, as well as pregnant or breastfeeding individuals, those with severe liver or heart disease, patients with bile duct obstruction, patients undergoing renal dialysis, individuals in a state of shock, and certain diabetic patients. Those with insufficient body fluids or salts should be cautious as hypotension may occur, and there is also a risk of sudden blood vessel dilation leading to a drop in blood pressure. Patients with heart disease or impaired kidney function must be closely monitored while taking this medication, as blood pressure may sometimes drop too low or kidney function may worsen. When taking this medication, side effects such as dizziness, headache, drowsiness, indigestion, skin rash, and edema may occur, so any abnormal symptoms should be consulted with a healthcare professional. Particularly, this medication may raise potassium levels in the blood, so when taken with potassium supplements or potassium-sparing diuretics, blood potassium levels should be monitored carefully. Avoid taking it with grapefruit juice, as it may excessively enhance blood pressure lowering effects. Women who are pregnant or planning to become pregnant are advised to choose alternative treatments with established safety rather than this medication. Breastfeeding women should discontinue breastfeeding or stop taking this medication since it may be transmitted in breast milk and affect the baby. It is recommended not to use this medication in children under 18 years old as the safety and efficacy have not been established. Elderly patients should start with a low dose, as renal and liver function may be reduced, leading to higher drug concentrations in the body, and their condition should be closely observed. In case of overdose, blood pressure may drop severely; therefore, notify healthcare professionals immediately for appropriate treatment. Store this medication in a tightly closed container, away from moisture, heat, and direct sunlight, out of reach of children.
Drug hypersensitivity, hyperkalemia, decreased libido, dizziness, headache, orthostatic hypotension, drowsiness, paresthesia, decreased sensation, syncope, vertigo, palpitations, rapid pulse, hypotension, orthostatic hypotension, dyspnea, cough, nausea, vomiting, dyspepsia, diarrhea, constipation, dry mouth, upper abdominal pain, rash, urticaria, muscle tension, limb pain, back pain, polyuria, erectile dysfunction, peripheral edema, edema, dependent edema, fatigue, asthenia, facial edema, decreased serum potassium, increased serum creatinine, increased serum uric acid, increased gamma-glutamyl transferase, decreased hemoglobin and hematocrit, cholelithiasis, female breast neoplasm, worsening of cerebral infarction, gum bleeding, orthostatic dizziness, chest pain, cold, increased CRP, fever, hemoptysis, excessive sneezing, runny nose, laryngitis, arthritis, flank pain, systemic pain, hypoglycemia, weight loss, heartburn, gastritis, shingles, diplopia, insomnia, asthenia, angioedema, chronic malabsorption syndrome-like intestinal disorder, rhabdomyolysis, acute renal failure, hair loss, itching, autoimmune hepatitis, flushing, fatigue, edema, palpitations, dizziness, headache, drowsiness, abdominal pain, nausea, gynecomastia, jaundice, elevated liver enzymes, leukopenia, thrombocytopenia, toxic epidermal necrolysis, hypotension, tachycardia, bradycardia, non-cardiogenic pulmonary edema
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C. This will help to safely preserve the medication's efficacy.
Pale yellow round film-coated tablet
30 tablets (10 tablets/PTP×3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Taeguk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.